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Objective: To compare the relative effects of intrapartum antibiotic prophylaxis regimens on patterns of
early-onset neonatal sepsis.
Methods: We performed an historical cohort study of 17 187 infants born at our center from September 1993
to February 2000. A risk-based strategy was employed prior to July 1996 and a screening-based strategy was
utilized thereafter. Ampicillin was utilized prior to March 1995 and penicillin was used thereafter.
Results: There were 75 cases of neonatal sepsis, 34 (4.10/1000) in the risk-based era and 41 (4.63/1000) in the
screening-based era (p = 0.62). There were fewer ampicillin-resistant isolates during the risk-based than
the screening-based era (32 versus 61%; p = 0.014). The only significant change in organism-specific sepsis
rates was an increase in the rate of infection caused by coagulase-negative staphylococci in the screening-based
era (0.36 versus 1.46/1000; p = 0.018), but 75% of infants infected with these organisms were not exposed to
β-lactam antibiotics within 72 h prior to delivery. For the risk- and screening-based eras, respectively, the rates
of Gram-negative sepsis (1.21 versus 1.46/1000; p = 0.65) and the proportions of Gram-negative pathogens
that were ampicillin-resistant (70 versus 77%; p = 1.0) were similar. The drug employed for prophylaxis did
not appear to affect the pattern of sepsis cases.
Conclusion: In our patient population, coagulase-negative staphylococci have become the most common cause
of early-onset neonatal sepsis. The cause of this shift in pathogen prevalence is uncertain and seemingly unrelated
to intrapartum antibiotic exposure.
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Guidelines for the prevention of perinatal group B
streptococcal disease using intrapartum anti-
biotic prophylaxis were issued by the Centers
for Disease Control and Prevention in 19961.
These guidelines were revised in 20022. Both
versions of the guidelines recommend penicillin
as the preferred agent for intrapartum antibiotic
prophylaxis and refer to ampicillin as an ‘accept-
able alternative’. Penicillin was recommended
preferentially due to its narrower spectrum and
presumably, its theoretical advantage in causing
less selection of β-lactam antibiotic-resistant
organisms. The more recent guidelines preferen-
tiallyrecommenduseofascreening-basedmethod
(over a risk-based method) of selecting women
to receive intrapartum antibiotic prophylaxis2.
This recommendation is based on a cohort study
that demonstrated that routine screening for
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 2003 The Parthenon Publishing Group 221group B streptococcus (GBS) during pregnancy
prevented more cases of early-onset neonatal
GBS disease (relative risk 0.46)3.
Retrospective and observational data from
multiple studies suggest that intrapartum anti-
biotic prophylaxis with ampicillin increases both
the incidence of early-onset neonatal infection
with Gram-negative bacteria of the Entero-
bacteriaceae family and the proportion of these
organisms that are resistant to ampicillin4–7. How-
ever, this association has not been consistently
demonstrated in all studies8,9. We are unaware of
any data that have been published that implicate
intrapartum antibiotic prophylaxis with penicillin
in increasing the likelihood of early-onset neo-
natal infection with Gram-negative organisms.
Unfortunately, nor are there any published data
that refute that such an association exists.
Early-onsetneonatalinfectionswithampicillin-
resistant Enterobacteriaceae result in an increased
mortality rate compared with infections with
ampicillin-sensitive bacteria4–6. Since the screen-
ing-based strategy results in more widespread use
of antibiotics, one concern regarding the most
recent recommendation for intrapartum antibiotic
prophylaxis is the potential for increasing the rates
of sepsis caused by more virulent pathogens. The
objectives of this study were to evaluate the rela-
tive effects of intrapartum antibiotic prophylaxis
regimens (risk- or screening-based approach) on
neonatalsepsispatternsandtocomparetherelative
effects of penicillin and ampicillin on these
sepsis patterns.
SUBJECTS AND METHODS
We performed an historical cohort analysis of
live-born infants delivered at Shands Hospital at
the University of Florida from September 1, 1993
to February 25, 2000. A risk-based strategy for
intrapartum antibiotic prophylaxis was employed
priortoJuly1,1996andascreening-basedstrategy
was utilized thereafter. Ampicillin was used for
prophylaxis prior to March 1, 1995 and penicillin
was used thereafter.
Infants were included in the cohort if they had
a positive blood culture during the first 7 days
of life. Infants born elsewhere and then trans-
ferred to our center for neonatal care were
excluded, as were infants whose cultures were of
organismsgenerallyconsideredtobecontaminants
(e.g. Corynebacterium sp., Bacillus sp.). Cases with
coagulase-negative staphylococci were included
onlyiftheinfantreceivedanti-staphylococcalanti-
biotics for at least 5 days. This stipulation was
included in an attempt to objectively eliminate
cases in which blood cultures positive for
coagulase-negative staphylococci clinically were
considered to represent contaminated cultures.
Cases of positive blood cultures within the first
7 days of life were identified from the laboratory
database for Shands Hospital at the University
of Florida that is maintained by the hospital’s
DepartmentofInformationServices.Bothaerobic
and anaerobic blood cultures were included.
During the entire study period, blood cultures
were obtained in aerobic and anaerobic resin
culture bottles and a pediatric blood culture
bottle and analyzed using an automated system
(Bactec, BD, Sparks, MD). Antibiotic suscept-
ibility testing was done using the MicroScan
minimum inhibitory concentration breakpoint
determination for both Gram-positive and
Gram-negative bacteria (Dade Behring, Inc.,
W. Sacramento, CA). The medical records of
these infants then were reviewed to determine
whether the subject met the criteria for inclusion
in the cohort. For those subjects meeting criteria
for inclusion, their records were abstracted for
demographic, clinical and outcome data. The
mothers of the infants included as subjects were
identified from the database maintained by
the Division of Maternal–Fetal Medicine in the
Department of Obstetrics and Gynecology and
the medical records of these women were
reviewed and abstracted for demographic data and
peripartum clinical information. The University
of Florida Health Center Institutional Review
Board approved the study.
The primary outcome variable was the propor-
tion of isolates causing early-onset neonatal sepsis
cases that were resistant to ampicillin. Isolates
with intermediate susceptibility were considered
resistant. Secondary outcomes included total and
organism-specific rates of early-onset sepsis,
susceptibility of Gram-negative isolates to ampi-
cillin, and neonatal mortality. We also evaluated
the effect of exposure to any β-lactam antibiotic
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patterns. All statistical tests were two-tailed and
used an α of 0.05. The uncorrected chi-square
and Fisher’s exact tests were used to analyze
categorical data. The unpaired Student’s t-test and
Mann–Whitney U were utilized for continuous
data, as appropriate. To detect a 100% increase in
rate of ampicillin resistance from 30% during the
risk-based strategy to 60% during the screening-
based strategy, 84 subjects were needed (α = 0.05;
1-β = 0.80).
RESULTS
During the study period, 17 187 infants were
delivered at our center: 8287 during the risk-
based era and 8900 during the screening-based
era. Seventy-five infants met the criteria for
inclusion in this cohort study. Table 1 presents
the demographic data for subjects in the risk-
and screening-based era groups.
Shown in Table 2 are the total and organism-
specific sepsis rates for each era. In the risk- and
screening-based groups there were ten and 12
coagulase-negative staphylococci isolates, respec-
tively, that were considered to be contaminants,
and these cases were eliminated from further
analysis.
Considering all cases of early-onset neonatal
sepsis collectively, there was a lower proportion
of isolates resistant to ampicillin during the risk-
than the screening-based era (32 versus 61%;
p = 0.014). This increase in the proportion of
ampicillin-resistant cases was primarily due to the
increase in the proportion of cases caused by
coagulase-negative staphylococci (Table 2). The
proportion of Gram-negative isolates that were
resistant to ampicillin was similar between
groups (70 compared with 77% for the risk- and
screening-based eras, respectively; p = 1.0).
There was a trend toward increased mortality
during the screening-based era, but this difference
did not reach statistical significance (0 versus
9.8%; p = 0.13).
Considering the entire cohort collectively, 17
of 28 (61%) total isolates from subjects exposed
to β-lactam antibiotics within 72 h prior to
delivery were resistant to ampicillin, while 20 of
47 (43%) isolates from subjects not exposed
were resistant to ampicillin (p = 0.13). Of cases
of E. coli sepsis, eight of the 11 (73%) subjects
exposed to β-lactam antibiotics had ampicillin-
resistant isolates, while three of the four (75%)
unexposed subjects had ampicillin-resistant iso-
lates (p = 1.0). Similarly, of cases of sepsis caused
by any Gram-negative organism, 11 of the 14
(79%) subjects exposed to β-lactam antibiotics had
ampicillin-resistant isolates, while six of the
nine (67%) unexposed subjects had ampicillin-
resistant isolates (p = 0.64). No isolates of GBS,
and all isolates of coagulase-negative staphylo-
cocci, were resistant to ampicillin. During each
era, 75% of cases of early-onset sepsis caused by
coagulase-negative staphylococci occurred in
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Variable
Risk
(n = 34)
Screening
(n = 41) p value
Gestational age
(weeks)
Race
White
Black
Other
Birth weight
(grams)
Neonatal gender
Male
Delivery route
Vaginal
Cesarean
34.1 ± 5.3
14 (41)
18 (53)
2 (6)
2375 ± 1118
18 (53)
19 (56)
15 (44)
32.6 ± 5.8
19 (46)
18 (46)
4 (10)
2019 ± 1236
26 (63)
18 (44)
23 (56)
0.23
0.68
0.20
0.36
0.30
Data are presented as n (%) or mean ± standard deviation
Table 1 Demographic data for early-onset sepsis
cases occurring in the risk- and screening-based eras
Rates of sepsis
Risk
(n = 34)
Screening
(n = 41) p value
Overall
Group B streptococci
Escherichia coli
Total Gram-negative
Coagulase-negative
staphylococci
Other
34 (4.10)
14 (1.69)
7 (0.84)
10 (1.21)
3 (0.36)
7 (0.84)
41 (4.63)
9 (1.01)
8 (0.90)
13 (1.46)
13 (1.46)
6 (0.67)
0.62
0.22
0.91
0.65
0.018
0.67
Data are presented as n (rate per 1000)
Table 2 Total and organism-specific early-onset sepsis
rates for the risk- and screening-based erasinfants that were not exposed to β-lactam anti-
biotics within 72 h prior to delivery.
The majority of infants with early-onset sepsis
during each era were born preterm. During the
risk-based era, 18 (53%) of the 34 septic infants
were born prior to 37 weeks, compared with 29
(71%) of the 41 septic infants born during the
screening-based era (p = 0.11). Of cases of sepsis
caused by coagulase-negative staphylococci, all
three during the risk-based era and 11 of 13
during the screening-based era occurred in
preterm infants. Presented in Table 3 are the
total and organism-specific sepsis rates for each
era, stratified by term versus preterm delivery.
During the risk-based era, 4912 deliveries
occurred during the time period when ampicillin
was utilized and 3375 deliveries occurred when
penicillin was utilized. As noted in the larger (risk
versus screen) group comparisons, the ampicillin
and penicillin groups were similar with regard
to distributions of race, gender and delivery route
and mean gestational age at delivery and birth
weight.
Shown in Table 4 are the total and organism-
specific sepsis rates for each era, ampicillin or
penicillin, during the risk-based strategy era. In
the ampicillin and penicillin groups, respectively,
there were six and four coagulase-negative staphy-
lococci isolates that were considered to be con-
taminants. During the ampicillin and penicillin
eras, respectively, six of 17 (35%) and five of
17 (29%) isolates were resistant to ampicillin.
All four of the Gram-negative isolates in the ampi-
cillin group and four of the six isolates in the
penicillin group were resistant to ampicillin
(p = 0.47).
In the entire cohort, only three infants were
infected with bacterial isolates that had inter-
mediate susceptibility to ampicillin. One of
these infants was delivered during the risk-based
era and two of them were delivered during the
screening-based era. Only one of these infants
(delivered during the screening-based era) was
exposed to β-lactam antibiotics within 72 h prior
to delivery. As described in the Subjects and
Methods section, these isolates were considered
to be resistant to ampicillin. If they had been con-
sidered susceptible, the results of the statistical
comparisons would not be substantially different.
DISCUSSION
Intrapartum antibiotic prophylaxis is recom-
mended, not as a permanent solution to perinatal
GBSdisease, but as a temporizing measure until
other methods of control are available and can
be implemented (e.g. vaccination)1,2. Widespread
adoption of intrapartum antibiotic prophylaxis
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Rates of sepsis
Risk
(n = 34)
Screening
(n = 41) p value
Overall
Term
Preterm
Group B streptococci
Term
Preterm
Escherichia coli
Term
Preterm
Total Gram-negative
Term
Preterm
Coagulase-negative
staphylococci
Term
Preterm
Other
Term
Preterm
16 (2.45)
18 (10.22)
12 (1.84)
2 (1.14)
3 (0.46)
4 (2.27)
3 (0.46)
7 (3.98)
0 (0.00)
3 (1.70)
1 (0.15)
6 (3.41)
12 (1.75)
29 (14.30)
6 (0.87)
3 (1.48)
4 (0.58)
4 (1.97)
4 (0.58)
9 (4.44)
2 (0.29)
11 (5.42)
0 (0.00)
6 (2.96)
0.45
0.30
0.16
1.0
1.0
1.0
1.0
1.0
0.50
0.07
0.49
1.0
Data are presented as n (rate per 1000)
Table 3 Total and organism-specific early-onset sepsis
rates for the risk- and screening-based eras, stratified by
term (≥ 37 weeks gestation) or preterm delivery
Rates of sepsis
Ampicillin
(n = 17)
Penicillin
(n = 17) p value
Overall
Group B streptococci
Escherichia coli
Total Gram-negative
Coagulase-negative
staphylococci
Other
17 (3.46)
7 (1.43)
3 (0.61)
4 (0.81)
2 (0.41)
4 (0.81)
17 (5.04)
7 (2.07)
4 (1.19)
6 (1.78)
1 (0.30)
3 (0.89)
0.27
0.48
0.45
0.33
1.0
1.0
Data are presented as n (rate per 1000)
Table 4 Total and organism-specific early-onset sepsis
rates  for  the  ampicillin  and  penicillin  portions  of  the
risk-based eraresulted in a 65% decrease in the incidence of
early-onset neonatal GBSinfection from 1993 to
199810. In addition, use of a screening-based, as
opposed to a risk-based approach, has now been
associated with fewer maternal infections11 and
fewer cases of neonatal GBS infections3.
However, a prior study from our institution
reported that use of a screening-based approach
results in more women receiving antibiotics in
labor11. In some studies, more widespread use of
intrapartumantibioticprophylaxishasbeenassoci-
ated with increased rates of early-onset neonatal
infection with ampicillin-resistant Gram-negative
bacteria4–7. This change in the pattern of neonatal
sepsis is important, since the mortality rate for
infants with ampicillin-resistant Gram-negative
infections is approximately 50%, while the rate for
infants with GBSsepsis is in the range of 5% 5,6.
Furthermore, our recent clinical trial lends
credence to the biological plausibility that
intrapartum antibiotic prophylaxis (with either
ampicillin or penicillin) may increase the likeli-
hood of neonatal infection with ampicillin-
resistant Gram-negative organisms12.
In contrast to our hypothesis, we did not show
an increase in the proportion of early-onset neo-
natal sepsis cases caused by ampicillin-resistant
Gram-negative organisms coincident with the
adoption of a screening-based method for
selecting candidates for intrapartum antibiotic
prophylaxis. Instead, we demonstrated that
coagulase-negative staphylococci (previously the
third most common cause) have become the most
common cause of early-onset neonatal infections
at our center. Our results do show a significant
increase in the proportion of pathogens that are
resistant to ampicillin, coincident with using the
screening-based regimen. However, the most
striking (and the only statistically significant)
change in pathogen-specific infection rates was
this increase in the incidence of cases caused by
coagulase-negative staphylococci.
Furthermore, three-quarters of the infants who
developed infections with coagulase-negative
staphylococci were not exposed to any β-lactam
antibiotic within the 72 h prior to delivery.
This fact argues against intrapartum antibiotic
prophylaxis having had a major role in the shift
in sepsis patterns having occurred. Certainly, the
reasons for any such shift are multiple and
complex.
We observed a trend toward a higher pro-
portion of ampicillin-resistant organisms causing
early-onset sepsis in those infants who had been
exposedtoanyβ-lactamantibioticduringthe72 h
prior to delivery, regardless of the purpose for
which the antibiotic was administered. This
exposure was due, in many cases, to antibiotic
therapy aimed at prolonging the latency period
in the setting of preterm premature rupture of
the membranes. Prior to March 1, 1998, our
regimen for preterm premature rupture of the
membranes was intravenous ticarcillin-clavulanate
for 48 h followed by oral amoxicillin-clavulanate
for another 5 days. Since March 1, 1998, our
regimen has been a single oral dose of azithro-
mycin plus intravenous ampicillin for 48 h
followed by oral amoxicillin for another 5 days.
Perhaps the pattern of antibiotic use throughout
pregnancy, or in the population in general, may
have contributed to the change in the proportion
of ampicillin-resistant organisms causing early-
onset sepsis. Almost half of the women who
receive intrapartum antibiotic prophylaxis at our
center receive additional antibiotics during their
antepartum course12.
However, the shift in prevalence of pathogens
causing early-onset neonatal sepsis may have more
to do with factors other than antibiotic prescrib-
ing practices. In the early part of the twentieth
century, group A streptococci were the most
frequent cause of perinatal infections. Later, E. coli
was the most frequently isolated pathogen. By
the 1970s, GBSbecame the most frequent cause of
early-onset neonatal sepsis13. The reason(s) for
this shifting pattern in pathogens causing early-
onset neonatal sepsis have not been explained
satisfactorily. Perhaps we will see (and are already
seeing at our center) coagulase-negative staphylo-
cocci emerge as the most important pathogen in
cases of early-onset neonatal infections.
As in our recent clinical trial12, we documented
no advantage of penicillin over ampicillin in this
study.Thesubgroupanalysiscomparingtheeffects
of these two antibiotics in this study is rather
small and sweeping conclusions would be
inappropriate. However, we continue to believe
that the choice of agent for intrapartum antibiotic
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cost, availability and patient tolerability, rather
than any theoretical advantage of penicillin over
ampicillin.
Since intrapartum antibiotic prophylaxis is only
considered a temporary and imperfect solution to
early-onset neonatal GBSdisease, ongoing sur -
veillance of patterns of sepsis cases remains an
important endeavor. Efforts aimed at optimizing
the process for selecting candidates for prophylaxis
and at solutions other than antibiotic prophy-
laxis should continue to receive our attention.
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